First Manhattan’s Sabra Healthcare REIT SBRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-10,000
Closed -$173K 706
2024
Q4
$173K Hold
10,000
﹤0.01% 660
2024
Q3
$186K Hold
10,000
﹤0.01% 657
2024
Q2
$154K Hold
10,000
﹤0.01% 637
2024
Q1
$148K Hold
10,000
﹤0.01% 706
2023
Q4
$143K Hold
10,000
﹤0.01% 697
2023
Q3
$139K Hold
10,000
﹤0.01% 716
2023
Q2
$118K Hold
10,000
﹤0.01% 734
2023
Q1
$115K Hold
10,000
﹤0.01% 777
2022
Q4
$124K Hold
10,000
﹤0.01% 798
2022
Q3
$131K Hold
10,000
﹤0.01% 774
2022
Q2
$139K Sell
10,000
-12,000
-55% -$160K ﹤0.01% 784
2022
Q1
$327K Hold
22,000
﹤0.01% 665
2021
Q4
$297K Hold
22,000
﹤0.01% 670
2021
Q3
$323K Hold
22,000
﹤0.01% 644
2021
Q2
$400K Buy
22,000
+12,000
+120% +$214K ﹤0.01% 601
2021
Q1
$173K Buy
+10,000
New +$176K ﹤0.01% 730

Other funds holding SBRA

First Manhattan's SBRA Position: Q1 2025 in Review

First Manhattan sold out of Sabra Healthcare REIT (SBRA) in Q1 2025, closing a stake of 10,000 shares — an estimated $173K sold.

First Manhattan first reported a position in SBRA in Q1 2021 and held it in 16 quarters. The position peaked at $400K in Q2 2021. 403 funds tracked by Wall St. Rank hold SBRA as of Q1 2025.

  • First Manhattan reported no remaining Sabra Healthcare REIT position as of Q1 2025 after selling out during the quarter.
  • First Manhattan sold 10,000 Sabra Healthcare REIT shares in Q1 2025, an estimated $173K.
  • First Manhattan first reported a position in Sabra Healthcare REIT in Q1 2021 and held it in 16 quarters.
  • First Manhattan's Sabra Healthcare REIT position peaked at $400K in Q2 2021.
  • 403 funds tracked by Wall St. Rank held Sabra Healthcare REIT as of Q1 2025.

Based on First Manhattan's 13F filing for Q1 2025, filed 15 May 2025.